Prevalence of Metabolic Syndrome in Men with Erectile Dysfunction

Abstract

rectile dysfunction, as defined by the International Consultation on Sexual Medicine, is the consistent and recurrent inability to acquire or sustain an erection of sufficient rigidity and duration to engage in satisfactory sexual intercourse. Although advances in screening (ie, penile duplex ultrasound, endocrine evaluation, etc) and treatment (ie, oral pharmacotherapy, intracavernosal injection therapy, and penile prosthesis) have improved ED detection and management, it is not uncommon for men with sexual dysfunction to be dismissed without a proper workup for non-psychogenic etiologies. Over the past decade, an association between ED and CVD has been identified. While causality remains difficult to establish, ED may be an indicator of systemic disease, with both ED and CVD stemming from a common etiology. A better understanding of this association is warranted in order to properly counsel, screen, and treat patients presenting with ED. The aim of this study was to identify the prevalence of MetS among patients with ED. This was a cross sectional study conducted on 200 patients attending the Andrology clinic of Dermatology, Venereology and Andrology department, Ain-Shams